Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3

The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. Blood samples from 42 sows and 216 horses were collected, and their seropre...

Full description

Saved in:
Bibliographic Details
Published inClinical and Experimental Vaccine Research Vol. 5; no. 1; pp. 26 - 30
Main Authors Kang, Bo-Kyu, Hwang, Jeong-Min, Moon, Hyoungjoon, Han, Sang-Yoon, Kim, Jong-Man, Yang, Dong-Kun, Park, Bong-Kyun, Song, Daesub
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Vaccine Society 01.01.2016
The Korean Vaccine Society
대한백신학회
Subjects
Online AccessGet full text
ISSN2287-3651
2287-366X
DOI10.7774/cevr.2016.5.1.26

Cover

Abstract The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. Blood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test. We found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test. There is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests.
AbstractList PURPOSEThe Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests.MATERIALS AND METHODSBlood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test.RESULTSWe found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test.CONCLUSIONThere is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests.
Purpose: The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. Materials and Methods: Blood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test. Results: We found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test. Conclusion: There is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests. KCI Citation Count: 3
The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. Blood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test. We found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test. There is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests.
Purpose The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the antigenic relationship between the two genotypes by using antibody tests. Materials and Methods Blood samples from 42 sows and 216 horses were collected, and their seroprevalence was monitored using the hemagglutination inhibition and virus neutralization tests. Antisera against JEV G1 and G3 were isolated and prepared from guinea pigs. The cross-reactivity of these two viruses was then compared using the neutralizing antibody test. Results We found that there was a difference in the seropositive ratios of JEV G1 and G3. However, the difference was dependent on the antibody test used. There was also an observed difference in the antigenicity between the two genotypes, as ascertained using the neutralizing antibody test. Conclusion There is an evident difference in JEV antigenicity between the genotypes G1 and G3. Therefore, we propose monitoring of the seroprevalence of JEV, and reevaluating the antigenicity of the current vaccine by using the relevant tests.
Author Bo-Kyu Kang
Daesub Song
Dong-Kun Yang
Sang-Yoon Han
Hyoungjoon Moon
Jong-Man Kim
Jeong-Min Hwang
Bong-Kyun Park
AuthorAffiliation 1 Research Unit, Green Cross Veterinary Products, Yongin, Korea
2 Animal and Plant Quarantine Agency, Anyang, Korea
3 Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea
4 College of Pharmacy, Korea University, Sejong, Korea
AuthorAffiliation_xml – name: 2 Animal and Plant Quarantine Agency, Anyang, Korea
– name: 1 Research Unit, Green Cross Veterinary Products, Yongin, Korea
– name: 4 College of Pharmacy, Korea University, Sejong, Korea
– name: 3 Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea
Author_xml – sequence: 1
  givenname: Bo-Kyu
  orcidid: 0000-0001-5840-468X
  surname: Kang
  fullname: Kang, Bo-Kyu
  organization: Research Unit, Green Cross Veterinary Products, Yongin, Korea
– sequence: 2
  givenname: Jeong-Min
  orcidid: 0000-0003-4272-1220
  surname: Hwang
  fullname: Hwang, Jeong-Min
  organization: Research Unit, Green Cross Veterinary Products, Yongin, Korea
– sequence: 3
  givenname: Hyoungjoon
  orcidid: 0000-0001-6211-8758
  surname: Moon
  fullname: Moon, Hyoungjoon
  organization: Research Unit, Green Cross Veterinary Products, Yongin, Korea
– sequence: 4
  givenname: Sang-Yoon
  orcidid: 0000-0001-6608-724X
  surname: Han
  fullname: Han, Sang-Yoon
  organization: Research Unit, Green Cross Veterinary Products, Yongin, Korea
– sequence: 5
  givenname: Jong-Man
  orcidid: 0000-0001-8479-0393
  surname: Kim
  fullname: Kim, Jong-Man
  organization: Research Unit, Green Cross Veterinary Products, Yongin, Korea
– sequence: 6
  givenname: Dong-Kun
  orcidid: 0000-0001-5765-3043
  surname: Yang
  fullname: Yang, Dong-Kun
  organization: Animal and Plant Quarantine Agency, Anyang, Korea
– sequence: 7
  givenname: Bong-Kyun
  orcidid: 0000-0002-4301-8740
  surname: Park
  fullname: Park, Bong-Kyun
  organization: Department of Veterinary Medicine Virology Laboratory, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Korea
– sequence: 8
  givenname: Daesub
  orcidid: 0000-0002-2759-1061
  surname: Song
  fullname: Song, Daesub
  organization: College of Pharmacy, Korea University, Sejong, Korea
BackLink https://cir.nii.ac.jp/crid/1874242817956299392$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/26866021$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002131831$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9ks9rFDEUx4NUbK29e5KAHvSwY5LJj5mLUBZ_VAqCVPBkyGTedGNnkzHJrvS_N7O7LdqDl7xAvt9PHt_3nqIjHzwg9JySSinF31rYxooRKitR0YrJR-iEsUYtaim_H93fBT1GZym5jnCu6ppy-gQdM9lISRg9QT-WYT2Z6FLwOAw4rwAbn901eGdxhNFkF3xauQl3kH8DePzZTMZDAgzewrQyo8su4a2Lm4SLLeTbCRKmBdPj-hl6PJgxwdmhnqJvH95fLT8tLr98vFieXy4sb-q8gEbxriYcBs6gJb3tBJW0Z8pK6AknnQQmaSOUHcjQQDf0QhBiQDIu2pr39Sl6s-f6OOgb63Qwblevg76J-vzr1YWmBUEIL9p3e-206dbQW_A5mlFP0a1NvN05_33xblU4W80VZ6IVBfD6AIjh1wZS1muXLIxjySVskqaqpE7aoizSlw-kP8Mm-hKFZlI2LRNKzcAXf3d038rdmIpA7gU2hpQiDNq6vBtNadCNmhI9r4SeV0LPK6GFpsVejOSB8Y79H8urQ5TOlW_mk5bxMM4aqlohWdvWLav_AGMixHc
CitedBy_id crossref_primary_10_3390_pathogens10121534
crossref_primary_10_1038_s44298_024_00025_5
crossref_primary_10_1111_tbed_13903
crossref_primary_10_1080_21645515_2017_1285472
crossref_primary_10_3390_v14112480
crossref_primary_10_4167_jbv_2016_46_4_231
crossref_primary_10_1371_journal_pntd_0007601
crossref_primary_10_7774_cevr_2020_9_2_102
Cites_doi 10.1099/0022-1317-71-12-2915
10.1086/521911
10.4142/jvs.2004.5.2.125
10.1292/jvms.10-0502
10.1016/j.vetmic.2013.01.017
10.1099/vir.0.79797-0
10.4142/jvs.2008.9.4.381
10.3201/eid1411.080542
10.4236/ojvm.2012.23020
10.1016/S0065-3527(08)60316-4
10.1371/journal.pntd.0002411
10.1292/jvms.68.293
10.1099/vir.0.82185-0
10.1128/JVI.02686-13
10.7774/cevr.2014.3.2.212
10.1002/jmv.1890440204
10.3201/eid1501.080311
10.4142/jvs.2007.8.2.197
10.1186/1743-422X-7-127
10.4142/jvs.2004.5.3.197
10.1128/JVI.02050-14
ContentType Journal Article
Copyright 2016. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Korean Vaccine Society. 2016
Copyright_xml – notice: 2016. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Korean Vaccine Society. 2016
DBID RYH
AAYXX
CITATION
NPM
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
ACYCR
DOI 10.7774/cevr.2016.5.1.26
DatabaseName CiNii Complete
CrossRef
PubMed
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central
ProQuest One Academic Middle East (New)
ProQuest One Academic UKI Edition
ProQuest Central Essentials
ProQuest Central Korea
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2287-366X
EndPage 30
ExternalDocumentID oai_kci_go_kr_ARTI_1261004
PMC4742595
26866021
10_7774_cevr_2016_5_1_26
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID 5-W
8JR
8XY
AAKDD
ABDBF
ACUHS
ADBBV
ADRAZ
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
DIK
EF.
GROUPED_DOAJ
HYE
KQ8
M48
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RNS
RPM
RYH
TUS
AAYXX
CITATION
NPM
ABUWG
AZQEC
DWQXO
PKEHL
PQEST
PQQKQ
PQUKI
7X8
PUEGO
5PM
ACYCR
ID FETCH-LOGICAL-c483t-e874b304ef42e90dcb5161d27c6ed040b6e261857cf0f8ebfd5500ae6245934d3
IEDL.DBID M48
ISSN 2287-3651
IngestDate Wed Feb 05 03:35:56 EST 2025
Thu Aug 21 13:14:31 EDT 2025
Thu Sep 04 18:33:15 EDT 2025
Mon Jun 30 03:49:02 EDT 2025
Thu Jan 02 22:22:10 EST 2025
Tue Jul 01 01:52:45 EDT 2025
Thu Apr 24 22:57:06 EDT 2025
Fri Jun 27 00:05:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Japanese encephalitis virus
Genotype
Cross reaction
Seroprevalence
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c483t-e874b304ef42e90dcb5161d27c6ed040b6e261857cf0f8ebfd5500ae6245934d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
G704-SER000004476.2016.5.1.009
http://dx.doi.org/10.7774/cevr.2016.5.1.26
ORCID 0000-0001-5765-3043
0000-0003-4272-1220
0000-0001-8479-0393
0000-0001-5840-468X
0000-0001-6211-8758
0000-0002-2759-1061
0000-0001-6608-724X
0000-0002-4301-8740
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.7774/cevr.2016.5.1.26
PMID 26866021
PQID 2668925775
PQPubID 5485050
PageCount 5
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1261004
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4742595
proquest_miscellaneous_1765109953
proquest_journals_2668925775
pubmed_primary_26866021
crossref_citationtrail_10_7774_cevr_2016_5_1_26
crossref_primary_10_7774_cevr_2016_5_1_26
nii_cinii_1874242817956299392
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-01-01
2016-00-00
2016-Jan
20160101
2016-01
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Clinical and Experimental Vaccine Research
PublicationTitleAlternate Clin Exp Vaccine Res
PublicationYear 2016
Publisher Korean Vaccine Society
The Korean Vaccine Society
대한백신학회
Publisher_xml – name: Korean Vaccine Society
– name: The Korean Vaccine Society
– name: 대한백신학회
References Fan (10.7774/cevr.2016.5.1.26_ref20) 2013; 163
Westaway (10.7774/cevr.2016.5.1.26_ref21) 1987; 33
Chen (10.7774/cevr.2016.5.1.26_ref11) 1990; 71
Yamanaka (10.7774/cevr.2016.5.1.26_ref16) 2006; 68
Yang (10.7774/cevr.2016.5.1.26_ref9) 2008; 9
Gubler (10.7774/cevr.2016.5.1.26_ref1) 2007; 45
Ku (10.7774/cevr.2016.5.1.26_ref23) 1994; 44
Yang (10.7774/cevr.2016.5.1.26_ref8) 2014; 3
Nitatpattana (10.7774/cevr.2016.5.1.26_ref13) 2008; 14
Nga (10.7774/cevr.2016.5.1.26_ref14) 2004; 85
Han (10.7774/cevr.2016.5.1.26_ref3) 2014; 88
Shimojima (10.7774/cevr.2016.5.1.26_ref6) 2011; 73
Yun (10.7774/cevr.2016.5.1.26_ref15) 2010; 7
Yang (10.7774/cevr.2016.5.1.26_ref22) 2004; 5
Yang (10.7774/cevr.2016.5.1.26_ref19) 2007; 8
Erlanger (10.7774/cevr.2016.5.1.26_ref2) 2009; 15
Lindenbach (10.7774/cevr.2016.5.1.26_ref10) 2001
Wang (10.7774/cevr.2016.5.1.26_ref12) 2007; 88
Schuh (10.7774/cevr.2016.5.1.26_ref5) 2014; 88
Schuh (10.7774/cevr.2016.5.1.26_ref4) 2013; 7
Yang (10.7774/cevr.2016.5.1.26_ref7) 2012; 2
Lee (10.7774/cevr.2016.5.1.26_ref17) 1956; 4
Yang (10.7774/cevr.2016.5.1.26_ref18) 2004; 5
15365233 - J Vet Sci. 2004 Sep;5(3):197-205
17325361 - J Gen Virol. 2007 Mar;88(Pt 3):885-94
25003095 - Clin Exp Vaccine Res. 2014 Jul;3(2):212-9
20546562 - Virol J. 2010 Jun 14;7:127
15166447 - J Gen Virol. 2004 Jun;85(Pt 6):1625-31
2273391 - J Gen Virol. 1990 Dec;71 ( Pt 12):2915-22
7852952 - J Med Virol. 1994 Oct;44(2):122-31
17879923 - Clin Infect Dis. 2007 Oct 15;45(8):1039-46
16598178 - J Vet Med Sci. 2006 Mar;68(3):293-5
17519576 - J Vet Sci. 2007 Jun;8(2):197-9
19116041 - Emerg Infect Dis. 2009 Jan;15(1):1-7
19043313 - J Vet Sci. 2008 Dec;9(4):381-5
3035906 - Adv Virus Res. 1987;33:45-90
25056890 - J Virol. 2014 Oct;88(19):11469-79
21233594 - J Vet Med Sci. 2011 Jun;73(6):813-6
15192339 - J Vet Sci. 2004 Jun;5(2):125-30
18976565 - Emerg Infect Dis. 2008 Nov;14(11):1762-5
24501419 - J Virol. 2014 Apr;88(8):4522-32
23415032 - Vet Microbiol. 2013 May 3;163(3-4):248-56
24009790 - PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2411
References_xml – volume: 71
  start-page: 2915
  issue: Pt 12
  year: 1990
  ident: 10.7774/cevr.2016.5.1.26_ref11
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-71-12-2915
– volume: 45
  start-page: 1039
  year: 2007
  ident: 10.7774/cevr.2016.5.1.26_ref1
  publication-title: Clin Infect Dis
  doi: 10.1086/521911
– volume: 5
  start-page: 125
  year: 2004
  ident: 10.7774/cevr.2016.5.1.26_ref18
  publication-title: J Vet Sci
  doi: 10.4142/jvs.2004.5.2.125
– volume: 73
  start-page: 813
  year: 2011
  ident: 10.7774/cevr.2016.5.1.26_ref6
  publication-title: J Vet Med Sci
  doi: 10.1292/jvms.10-0502
– volume: 163
  start-page: 248
  year: 2013
  ident: 10.7774/cevr.2016.5.1.26_ref20
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2013.01.017
– volume: 85
  start-page: 1625
  issue: Pt 6
  year: 2004
  ident: 10.7774/cevr.2016.5.1.26_ref14
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.79797-0
– volume: 9
  start-page: 381
  year: 2008
  ident: 10.7774/cevr.2016.5.1.26_ref9
  publication-title: J Vet Sci
  doi: 10.4142/jvs.2008.9.4.381
– volume: 14
  start-page: 1762
  year: 2008
  ident: 10.7774/cevr.2016.5.1.26_ref13
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1411.080542
– volume: 2
  start-page: 120
  year: 2012
  ident: 10.7774/cevr.2016.5.1.26_ref7
  publication-title: Open J Vet Med
  doi: 10.4236/ojvm.2012.23020
– volume: 33
  start-page: 45
  year: 1987
  ident: 10.7774/cevr.2016.5.1.26_ref21
  publication-title: Adv Virus Res
  doi: 10.1016/S0065-3527(08)60316-4
– volume: 4
  start-page: 21
  year: 1956
  ident: 10.7774/cevr.2016.5.1.26_ref17
  publication-title: Res Rep Natl Inst Vet Res
– volume: 7
  start-page: e2411
  year: 2013
  ident: 10.7774/cevr.2016.5.1.26_ref4
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0002411
– start-page: 991
  volume-title: Fields virology
  year: 2001
  ident: 10.7774/cevr.2016.5.1.26_ref10
– volume: 68
  start-page: 293
  year: 2006
  ident: 10.7774/cevr.2016.5.1.26_ref16
  publication-title: J Vet Med Sci
  doi: 10.1292/jvms.68.293
– volume: 88
  start-page: 885
  issue: Pt 3
  year: 2007
  ident: 10.7774/cevr.2016.5.1.26_ref12
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.82185-0
– volume: 88
  start-page: 4522
  year: 2014
  ident: 10.7774/cevr.2016.5.1.26_ref5
  publication-title: J Virol
  doi: 10.1128/JVI.02686-13
– volume: 3
  start-page: 212
  year: 2014
  ident: 10.7774/cevr.2016.5.1.26_ref8
  publication-title: Clin Exp Vaccine Res
  doi: 10.7774/cevr.2014.3.2.212
– volume: 44
  start-page: 122
  year: 1994
  ident: 10.7774/cevr.2016.5.1.26_ref23
  publication-title: J Med Virol
  doi: 10.1002/jmv.1890440204
– volume: 15
  start-page: 1
  year: 2009
  ident: 10.7774/cevr.2016.5.1.26_ref2
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1501.080311
– volume: 8
  start-page: 197
  year: 2007
  ident: 10.7774/cevr.2016.5.1.26_ref19
  publication-title: J Vet Sci
  doi: 10.4142/jvs.2007.8.2.197
– volume: 7
  start-page: 127
  year: 2010
  ident: 10.7774/cevr.2016.5.1.26_ref15
  publication-title: Virol J
  doi: 10.1186/1743-422X-7-127
– volume: 5
  start-page: 197
  year: 2004
  ident: 10.7774/cevr.2016.5.1.26_ref22
  publication-title: J Vet Sci
  doi: 10.4142/jvs.2004.5.3.197
– volume: 88
  start-page: 11469
  year: 2014
  ident: 10.7774/cevr.2016.5.1.26_ref3
  publication-title: J Virol
  doi: 10.1128/JVI.02050-14
– reference: 3035906 - Adv Virus Res. 1987;33:45-90
– reference: 15365233 - J Vet Sci. 2004 Sep;5(3):197-205
– reference: 23415032 - Vet Microbiol. 2013 May 3;163(3-4):248-56
– reference: 2273391 - J Gen Virol. 1990 Dec;71 ( Pt 12):2915-22
– reference: 21233594 - J Vet Med Sci. 2011 Jun;73(6):813-6
– reference: 25003095 - Clin Exp Vaccine Res. 2014 Jul;3(2):212-9
– reference: 16598178 - J Vet Med Sci. 2006 Mar;68(3):293-5
– reference: 15192339 - J Vet Sci. 2004 Jun;5(2):125-30
– reference: 15166447 - J Gen Virol. 2004 Jun;85(Pt 6):1625-31
– reference: 24501419 - J Virol. 2014 Apr;88(8):4522-32
– reference: 19116041 - Emerg Infect Dis. 2009 Jan;15(1):1-7
– reference: 17519576 - J Vet Sci. 2007 Jun;8(2):197-9
– reference: 17325361 - J Gen Virol. 2007 Mar;88(Pt 3):885-94
– reference: 24009790 - PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2411
– reference: 18976565 - Emerg Infect Dis. 2008 Nov;14(11):1762-5
– reference: 25056890 - J Virol. 2014 Oct;88(19):11469-79
– reference: 20546562 - Virol J. 2010 Jun 14;7:127
– reference: 19043313 - J Vet Sci. 2008 Dec;9(4):381-5
– reference: 7852952 - J Med Virol. 1994 Oct;44(2):122-31
– reference: 17879923 - Clin Infect Dis. 2007 Oct 15;45(8):1039-46
SSID ssib044733141
ssj0000816951
Score 1.9881208
Snippet The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the...
Purpose The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the...
PURPOSEThe Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the...
Purpose: The Japanese encephalitis virus (JEV) genotype circulating in Korea has changed from G3 to G1. Therefore, the purpose of this study was to compare the...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
nii
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 26
SubjectTerms Animals
Antibodies
Antigens
Climate change
Encephalitis
Horses
Immunization
Original
Original Article
Serology
Vaccines
Viruses
예방의학
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Pb9MwFLbYJiQuiN8ENmQQFw5ZG8d2nBOCadOYxIQQk3bCamxnjYaSkrST-O_5XpMGitAu6SFp9Pp--XvP7vsYe6uAikOqXeyMLmLplY4LHaaxDxr-NEuBOOjfyJ_P9emFPLtUl0PDrRuOVW5y4jpR-8ZRj3yChcTk8K9MvV_8jIk1inZXBwqNHbaHFGzg53sfj8-_fB27LEQrka85GIWgaNIq6fcqMwgxceGGRoIm-lAdolbUW2vTTl1VdG3L_4HPf89Q_rUonTxg9wc0yT_05n_I7oT6Ebvb80v-esy-H40sg7wpObAehyJp_mbleLs5BjevFnw4rsXPsHYSJyWngF_MCaRXHb-p2lXHaZwrdWw7nuA1nqdP2MXJ8bej03ggVIidNOkyDgaaT6cylFKEfOpdoQD4vMicDh7RDCuhoDIqc-W0NKEoPeqX6SxoIVWeSp8-Zbt1U4fnjJc5kJxAFZvNchnkzIRSeEPj3ZPS-bSI2GSjSuuGaeNEevHDouog5VtSviXlW2UTK3TE3o3fWPSTNm559gDWwYvpSqyCABoGqQVgDngrFxF7A7vZa1dZGp9Nn1eNvW4tioRPNoGYyA0R29-Y1Q6B29k_bhax1-NthBzto8AAzaqzSQY3ArJWacSe9V4wSiy00Rq4KWLZln-MD5A823fqar4e6y3xM1SuXtwu1kt2jxTRd4H22e6yXYUD4KJl8Wpw_t-MGAnd
  priority: 102
  providerName: ProQuest
Title Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3
URI https://cir.nii.ac.jp/crid/1874242817956299392
https://www.ncbi.nlm.nih.gov/pubmed/26866021
https://www.proquest.com/docview/2668925775
https://www.proquest.com/docview/1765109953
https://pubmed.ncbi.nlm.nih.gov/PMC4742595
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002131831
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Clinical and Experimental Vaccine Research , 2016, 5(1), , pp.26-30
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBZry2Avo7t7bYM29rIHp_FFsvw0mi6hK7SMsUCfJmJZbkyLk9lJWV_22_cd2_GWEQZ7kTCyD_K5SN_R5RzG3gmgYhtI4xolEzdMhXQTaQduaiX0aRoAcdBt5ItLeTYJz6_E1e_r0S0Dq62uHeWTmpS3_R_f7z_A4IFf-xFoHRt7R5E9PdkXfbh8coftYV6S5IpdtGC_HpeVJ-M6H6Pvk2VJ4TX7lluJbMxTO0WeU1lm24Do3-cp_5igxvvscYss-UmjCk_YA1s8ZQ-bXJP3z9i30y7jIJ9nHLiPg6kUizM3vFwfiZvlC94e3eLnmEcpPyUn41_MCLDnFb_Ly1XFKbQrrd5W3AOZlAfP2WQ8-np65rbJFVwTqmDpWgUpBIPQZqFv40FqEgHwl_qRkTaFZUNicK6UiEw2yJRNshS-zGBqpR-KOAjT4AXbLeaFfcV4FoPbPjzaaBqHNpwqm_mpolDvXmbSIHHY8ZqV2rSRxykBxq2GB0LM18R8TczXQnvalw57332xaKJu_OPdI0gHhKmkDIMAHQrDDIAdsFfsO-wt5KZvTK4plDbV13N9U2o4DJ-0h25inHDY4Vqseq2DoC1VjCEtEg570zXD_GhPBQKYryrtRVAjoGwROOxlowVdj32ppASGcli0oR_dC9SfzZYin9UhvkP8hojF6__gwwF7RE_N8tAh212WK3sEwLRMemzvZPhxOEY9HF1-_tKrFx56tXVQ-XP0C7qLFTY
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61qRC9IN4YWlgQHDi4idfetX1ACEqrpI8IoVbqiSXeXTdWkR3spKh_it_ITPyAINRbL87B9mY8Mzv7zT7mA3gtEBVbX2pXRzJxAyOkm0g7cI2V6E8THxEHnUY-HsvhaXBwJs7W4Fd7Foa2VbYxcRmoTaFpjryPA0kUo3-F4v3sh0usUbS62lJo1G5xaK9-YspWvRt9Qvu-4Xx_72R36DasAq4OIn_u2gj_HpN4mwbcxgOjE4Gox_BQS2vQpVFUzCoiEep0kEY2SQ2C-MHESh6I2A-Mj-2uw0ZAJ1p7sPFxb_z5SzerQzQW8ZLzkXPqvVJ49dpoiB_d1_aSSpB6ckfsYG4qV8bC9TzL6Fqm_wO7_-7Z_GsQ3L8Ldxr0yj7U7nYP1mx-H27VfJZXD-DrbsdqyIqUIbZkaDiq95lpVrbb7qbZjDXbw9gBjtXEgckowMymlBRkFbvMykXFqHwszRBXzMNmDPMfwumNqPoR9PIit0-ApTEiR45ZcziJAxtMIptyE1E5eS_Vxk8c6LeqVLqpbk4kG98VZjmkfEXKV6R8JZSnuHTgbffGrK7scc2z22gdbJiuxGKIwCbCUIbgEfFdzB14hXZTFzpTVK6bfs8LdVEqTEpGykMxMRY5sNWaVTWBolJ_3NqBl91t7OK0boMGKBaV8kJ0I0Tywnfgce0FncRcRlIiTnMgXPGP7gGSZ_VOnk2XZcQD_Az04afXi_UCbg9Pjo_U0Wh8-Aw2SSn1DNQW9Oblwm4jJpsnz5uOwODbTfe9300iRow
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61qUBcEG8MLSwIDhzcxGvv2j4gBG2jpoWoQlTqqUu8u26sVnawk6L-NX4dM_EDglBvvTgHO6vxPL_ZHc8AvBGIiq0vtasjmbiBEdJNpB24xkrUp4mPiIO-Rv4ylvvHwcGJOFmDX-23MFRW2frEpaM2haY98j4GkihG_QpFP23KIo52hx9mP1yaIEUnre04jVpFDu3VT0zfqvejXZT1W86He9929t1mwoCrg8ifuzZCUjCht2nAbTwwOhGIgAwPtbQG1RvJxgwjEqFOB2lkk9QgoB9MrOSBiP3A-LjuOmyEGBWDHmx82hsffe12eGikRbyc_8g5WbIUXn1OGiID-tpeUjtST26LbcxT5UpcXM-zjK5l-j_g-2_95l8BcXgP7jZIln2sVe8-rNn8AdyqZ1tePYTTnW7CIStShjiToRCp92emWdmW4E2zGWtKxdgBxm2ah8nI2cymlCBkFbvMykXFqJUs7RZXzMNlDPMfwfGNsPox9PIit0-BpTGiSI4ZdDiJAxtMIptyE1FreS_Vxk8c6LesVLrpdE4DNy4UZjzEfEXMV8R8JZSnuHTgXfePWd3l45pnt1A6uDBdaaIhgpwI3RoCScR6MXfgNcpNnetMUetu-j0r1HmpMEEZKQ_JRL_kwGYrVtU4jUr9UXEHXnW30dzpDAcFUCwq5YWoRojqhe_Ak1oLOoq5jKREzOZAuKIf3QNEz-qdPJsuW4oH-BoiFs-uJ-sl3EabU59H48PncId4Um9GbUJvXi7sFsKzefKisQMG32_a9H4DfslKuA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+antigenic+relationship+between+Japanese+encephalitis+virus+genotypes+1+and+3&rft.jtitle=Clinical+and+experimental+vaccine+research+%28Seoul%29&rft.au=Kang%2C+Bo-Kyu&rft.au=Hwang%2C+Jeong-Min&rft.au=Moon%2C+Hyoungjoon&rft.au=Han%2C+Sang-Yoon&rft.date=2016&rft.issn=2287-3651&rft.eissn=2287-366X&rft.volume=5&rft.issue=1&rft.spage=26&rft_id=info:doi/10.7774%2Fcevr.2016.5.1.26&rft.externalDBID=n%2Fa&rft.externalDocID=10_7774_cevr_2016_5_1_26
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-3651&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-3651&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-3651&client=summon